期刊文献+

老年患者肠球菌属感染的临床分布及耐药性分析 被引量:11

Clinical distribution of Enterococcusinfections in elderly patients and analysis of drug resistance
原文传递
导出
摘要 目的了解医院老年患者肠球菌属感染的临床分布特点及耐药性。方法使用法国生物梅里埃公司VITEK-32型全自动微生物分析仪及配套的GPI鉴定卡进行鉴定,并用K-B法进行抗菌药物敏感试验;数据处理应用WHONET5.4软件分析。结果临床老年患者感染的136例肠球菌属中粪肠球菌67株,占49.3%,屎肠球菌52株,占38.2%,主要发生在老年病科、ICU、肾内科和呼吸科,标本类型中尿液66株占44.1%,其次是痰液47株占34.5%;粪肠球菌对抗菌药物耐药性比屎肠球菌低,但粪肠球菌对四环素的耐药性却高于屎肠球菌,未发现耐万古霉素和替考拉宁的肠球菌属。结论肠球菌属对抗菌药物的耐药性不同,临床抗感染治疗应根据本地区分离菌株的体外抗菌药物敏感性试验结果为依据,选择敏感抗菌药物对其感染进行治疗。 OBJECTIVE To understand the clinical distribution and drug resistance of Enterococcus causing infections in elderly patients.METHODS By the means VITEK-32 type automatic microbial analyzer of French company BioMerieux and supporting GPI identification card,the identification of the strains was performed,and the antibiotic susceptibility testing was carried out using K-B method;the data processing was performed with WHONET5.4 software.RESULTS Of 136 strains of Enterococcus causing infections in elerly patients,there were 67(49.3%)strains of Enterococcus faecalis and 52(38.2%) strains of Enterococcus feces,those isolates mainly distributed in department of geriatrics,ICU,department of nephrology,and department of respiratory medicine;of the various specimen sources,66(44.1%) strains were isolated from urine,47(34.5%) strains were isolated from the sputum;the drug resistance of E.faecalis was lower than that of E.feces,but the resistance of E.faecalis to tetracycline was higher than that of E.feces,no strains of vancomycin or teicoplanin-resistant Enterococci were found.CONCLUSION Enterococci vary in drug resistance,it is necessary to choose the susceptible antibiotics for the clinical anti-infection treatment on the basis of the in vitro antibiotics susceptibility testing for the isolated strains from the local region.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2012年第17期3868-3870,共3页 Chinese Journal of Nosocomiology
关键词 老年患者 肠球菌属 耐药性 抗菌药物 Elderly patients Enterococcus Drug resistance Antibiotics
  • 相关文献

参考文献5

  • 1叶倩,胡龙华,贾坤茹,胡晓彦.医院感染肠球菌属的特征及耐药性分析[J].中华微生物学和免疫学杂志,2009,29(1):23-23. 被引量:8
  • 2Clinical and Laboratory Standards Institute.Performance Stand-ards for Antimicrobial Susceptibility test[S].M100-S18.CLSI,2008.
  • 3Nishimoto Y,Kobayashi N,Alam MM,et al.Analysis of the prevalence of terracycline resistance genes in clinical isolates of Enterococcus faecalis and Enterococcus faeciumin a Japa-nee hospital[J].Microb Drug Resim,2005,11(2):146-153.
  • 4Claesson C,Nilson LE,Kronvall G,et al.Antimicrobial ac-tivity of tigecycline and comparative agents against clinical i-solates of staphylococci and enterococci from ICUs and gener-al hospital wards at three Swedish university hospitals[J].Scand J Infect Dis,2009,41(3):171-181.
  • 5张媛,张鹏,吴尚为.耐万古霉素肠球菌耐药机制及实验室检测的研究进展[J].中华医院感染学杂志,2007,17(9):1178-1180. 被引量:27

二级参考文献18

  • 1李爽,张正.对万古霉素耐药的11株肠球菌的药敏表型及基因检测[J].中华检验医学杂志,2005,28(4):426-429. 被引量:17
  • 2McKessar SJ,Berry AM,Bell JM,et al.Genetic characterization of vanG,a novel vancomycin resistance locus of Enterococcus faecalis[J].Antimicrob Agents Chemother,2000,44(11):3224-3228.
  • 3Barbaba EM.Vancomycin-resistant enterococcal infection[J].N Engl J Med,2000,342(10):710-721.
  • 4Zhanel GG,Hoban DJ,Karlowsky JA.Nitrofurantoin is active against vancomycin-resistant enterococci[J].Antimicrob Agents Chemother,2001,45(1):324-326.
  • 5Christopher W.Antibiotics:actions,origins,resistance[M].ASM Press,2003.148-155.
  • 6Sanchez-Silos RM,Perez-Giraldo C,Martin P,et al.Pathogenicity of Enterococcus spp characteristics of 169 hospital isolates[J].Enferm Infect Microbiol Clin,2000,18(4):165-169.
  • 7Jeff P,John N,Gerard DW.Glycopeptide antibiotic resistance[J].Annu Rev Pharmacol Toxicol,2002,42 (3):381-408.
  • 8Robin P.Clinical impact of vancomycin-resistant enterococci[J].J Antimicrob Chemother,2003,51(3):13-21.
  • 9Zhanel GG,Laing NM,Nichol KA,et al.Antibiotic activity against urinary tract infection isolates of vancomycin-resistant enterococci:results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study[J].J Antimicrob Chemother,2003,52(3):382-388.
  • 10Intetsu K,Hiroe M,Takako L,et al.Antimicrobial susceptibility testing of vancomycin-resistant Enterococcus by the VITEK 2 system,and comparison with two NCCLS reference methods[J].J Med Microbiol,2004,53(12):1229-1232.

共引文献33

同被引文献74

  • 1李爽,张正.肠球菌耐药性的研究进展[J].中华检验医学杂志,2004,27(10):710-713. 被引量:34
  • 2李家泰,齐慧敏,李耘,代表中国细菌耐药监测研究组.2002—2003年中国医院和社区获得性感染革兰阳性细菌耐药监测研究[J].中华检验医学杂志,2005,28(3):254-265. 被引量:224
  • 3李爽,张正.粪肠球菌与屎肠球菌药敏表型和耐药基因的比较[J].临床检验杂志,2005,23(3):174-176. 被引量:28
  • 4黄支密,石晓霞,糜祖煌,仵蕾,秦玲,吴晶,陈榆,陆亚华.肠球菌抗生素耐药基因检测[J].中华医院感染学杂志,2006,16(1):1-5. 被引量:15
  • 5戴自英,汪复,张婴元.实用抗感染治疗学[M].北京:人民卫生出版社,2004:430.
  • 6Park YK,Jung SI, Park KH, et al. Independent emergence of colistin-resi seant Acinetobactey spp. isolates from Korea. Di- agn Microhiol Infect Dis, 2009,64 (1) : 43-51.
  • 7Shigemura K, Tanaka K, Okada H, et al. Pathogen occurence and antimicrobial susceptibility of urinary tract infection cases during a 20-year period ( 1983 - 2002 ) at a single institution in Japan[J].Jpn J Infect Dis,2005,58(5) :303 -308.
  • 8CLSI. Performance standards for antimicrobial susceptibility testing [ S ]. Twenty-First informational supplement. MIOO - S21,2011.
  • 9Lietzau S, Hoewner M, yon Banm H, et al. Antibiotic resistant fecal isolates of enterococci among unselected patients outside the clinical sector:an epidemiological study from Southern Germany [ J ]. Pharmacoepidemiol Drug Saf,2006,15 ( 4 ) : 275 - 277.
  • 10Clinical and Laboratory Standards Institute. MIO0 S24 Performance standards for antimicrobial susceptibility testing [ EB/ OL]. (2014 - O1 - O1 ) . http://www, techstreet, com/products/ 1870260.

引证文献11

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部